A multicenter registry of patients with rheumatoid arthritis starting biologic therapy in Japan: Tsurumai Biologics Communication Registry (TBCR) study
Not Applicable
Recruiting
- Conditions
- Rheumatoid arthritis
- Registration Number
- JPRN-UMIN000026558
- Lead Sponsor
- agoya University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 5000
Inclusion Criteria
Not provided
Exclusion Criteria
1) Patients who receive or have received biologics for any disease other than rheumatoid arthritis 2) Patients judged as inadequate at the discretion of physicians
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1) Secular changes in patient characteristics at initiation of biologics 2) Retention rate of biologic treatments 3) Efficacy and retention rate of methotrexate treatment
- Secondary Outcome Measures
Name Time Method 1) Predictors of discontinuation of biologic and methotrexate treatments 2) Correlation between efficacy of biologic and methotrexate treatments